|
1
|
Giusti F, Falchetti A, Franceschelli F,
Marini F, Tanini A and Brandi ML: Thyroid cancer: Current molecular
perspectives. J Oncol. 2010:3516792010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Braun J and Hüttelmaier S: Pathogenic
mechanisms of deregulated microRNA expression in thyroid carcinomas
of follicular origin. Thyroid Res. 4 Suppl 1:S12011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Leonardi GC, Candido S, Carbone M,
Colaianni V, Garozzo SF, Cinà D and Libra M: MicroRNAs and thyroid
cancer: Biological and clinical significance (Review). Int J Mol
Med. 30:991–999. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Benvenga S and Koch CA: Molecular pathways
associated with aggressiveness of papillary thyroid cancer. Curr
Genom. 15:162–170. 2014. View Article : Google Scholar
|
|
5
|
Wang T, Xu H, Qi M, Yan S and Tian X:
miRNA dysregulation and the risk of metastasis and invasion in
papillary thyroid cancer: A systematic review and meta-analysis.
Oncotarget. 9:5473–5479. 2017.PubMed/NCBI
|
|
6
|
Wang Y, Wei T, Xiong J, Chen P, Wang X,
Zhang L, Gao L and Zhu J: Association between genetic polymorphisms
in the promoter regions of Let-7 and risk of papillary thyroid
carcinoma: A case-control study. Medicine (Baltimore).
94:e18792015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Perdas E, Stawski R, Nowak D and Zubrzycka
M: The role of miRNA in papillary thyroid cancer in the context of
miRNA Let-7 family. Int J Mol Sci. 17:E9092016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lu X, Jia M, Liu Y, Liu Z, Xu H and Geng
Z: The role of microRNA-21 in papillary thyroid cancer cells. Chin
J Exp Surg. 29:1981–1982. 2012.(In Chinese with English
Abstract).
|
|
9
|
Samsonov R, Burdakov V, Shtam T,
Radzhabova Z, Vasilyev D, Tsyrlina E, Titov S, Ivanov M, Berstein
L, Filatov M, et al: Plasma exosomal miR-21 and miR-181a
differentiates follicular from papillary thyroid cancer. Tumour
Biol. 37:12011–12021. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Meng F, Henson R, Wehbe-Janek H, Ghoshal
K, Jacob ST and Patel T: Microrna-21 regulates expression of the
PTEN tumor suppressor gene in human hepatocellular cancer.
Gastroenterology. 133:647–658. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Qi L, Bart J, Tan LP, Platteel I, Sluis T,
Huitema S, Harms G, Fu L, Hollema H and Berg Av: Expression of
miR-21 and its targets (PTEN, PDCD4, TM1) in flat epithelial atypia
of the breast in relation to ductal carcinoma in situ and invasive
carcinoma. BMC Cancer. 9:1632009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhu S, Wu H, Wu F, Nie D, Sheng S and Mo
YY: MicroRNA-21 targets tumor suppressor genes in invasion and
metastasis. Cell Res. 18:350–359. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ma X, Kumar M, Choudhury SN, Buscaglia
Becker LE, Barker JR, Kanakamedala K, Liu MF and Li Y: Loss of the
miR-21 allele elevates the expression of its target genes and
reduces tumorigenesis. Proc Natl Acad Sci USA. 108:10144–10149.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu Y, Xu Y, Ji W, Li X, Sun B, Gao Q and
Su C: Anti-tumor activities of matrine and oxymatrine: Literature
review. Tumour Biol. 35:5111–5119. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
An Q, Han C, Zhou Y, Li F, Li D, Zhang X,
Yu Z, Duan Z and Kan Q: Matrine induces cell cycle arrest and
apoptosis with recovery of the expression of miR-126 in the A549
non-small cell lung cancer cell line. Mol Med Rep. 14:4042–4048.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wu L, Wang G, Wei J, Huang N, Zhang S,
Yang F, Li M, Zhou G and Wang L: Matrine derivative YF-18 inhibits
lung cancer cell proliferation and migration through
down-regulating Skp2. Oncotarget. 8:11729–11738. 2017.PubMed/NCBI
|
|
17
|
Lu Z, Xiao Y, Liu X, Zhang Z, Xiao F and
Bi Y: Matrine reduces the proliferation of A549 cells via the
p53/p21/PCNA/eIF4E signaling pathway. Mol Med Rep. 15:2415–2422.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Luo C, Zhu Y, Jiang T, Lu X, Zhang W, Jing
Q, Li J, Pang L, Chen K, Qiu F, et al: Matrine induced gastric
cancer MKN45 cells apoptosis via increasing pro-apoptotic molecules
of Bcl-2 family. Toxicology. 229:245–252. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li H, Xie S, Liu X, Wu H, Lin X, Gu J,
Wang H and Duan Y: Matrine alters microRNA expression profiles in
SGC-7901 human gastric cancer cells. Oncol Rep. 32:2118–2126. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
He M, Jiang L, Li B, Wang G, Wang J and Fu
Y: Oxymatrine suppresses the growth and invasion of MG63 cells by
up-regulating PTEN and promoting its nuclear translocation.
Oncotarget. 8:65100–65110. 2017.PubMed/NCBI
|
|
21
|
Peng X, Zhou D, Wang X, Hu Z, Yan Y and
Huang J: Matrine suppresses proliferation and invasion of SGC7901
cells through inactivation of PI3K/Akt/uPA pathway. Ann Clin Lab
Sci. 46:457–462. 2016.PubMed/NCBI
|
|
22
|
Niu H, Zhang Y, Wu B, Zhang Y, Jiang H and
He P: Matrine induces the apoptosis of lung cancer cells through
downregulation of inhibitor of apoptosis proteins and the Akt
signaling pathway. Oncol Rep. 32:1087–1093. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li LQ, Li XL, Wang L, Du WJ, Guo R, Liang
HH, Liu X, Liang DS, Lu YJ, Shan HL and Jiang HC: Matrine inhibits
breast cancer growth via miR-21/PTEN/Akt pathway in MCF-7 cells.
Cell Physiol Biochem. 30:631–641. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Oldham ED, Nunes LM, Varela-Ramirez A,
Rankin SE, Knutson BL, Aguilera RJ and Lehmler HJ: Cytotoxic
activity of triazole-containing alkyl β-D-glucopyranosides on a
human T-cell leukemia cell line. Chem Cent J. 9:32015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Robles-Escajeda E, Lerma D, Nyakeriga AM,
Ross JA, Kirken RA, Aguilera RJ and Varela-Ramirez A: Searching in
mother nature for anti-cancer activity: Anti-proliferative and
pro-apoptotic effect elicited by green barley on leukemia/lymphoma
cells. PLoS One. 8:e735082013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jin H, Sun Y, Wang S and Cheng X: Matrine
activates PTEN to induce growth inhibition and apoptosis in
V600EBRAF harboring melanoma cells. Int J Mol Sci. 14:16040–16057.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fragni M, Bonini SA, Bettinsoli P, Bodei
S, Generali D, Bottini A, Spano PF, Memo M and Sigala S: The
miR-21/PTEN/Akt signaling pathway is involved in the anti-tumoral
effects of zoledronic acid in human breast cancer cell lines.
Naunyn Schmiedebergs Arch Pharmacol. 389:529–538. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lv C, Hao Y and Tu G: MicroRNA-21 promotes
proliferation, invasion and suppresses apoptosis in human
osteosarcoma line MG63 through PTEN/Akt pathway. Tumour Biol.
37:9333–9342. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yu P, Liu Q, Liu K, Yagasaki K, Wu E and
Zhang G: Matrine suppresses breast cancer cell proliferation and
invasion via VEGF-Akt-NF-kappaB signaling. Cytotechnology.
59:219–229. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liang CZ, Zhang JK, Shi Z, Liu B, Shen CQ
and Tao HM: Matrine induces caspase-dependent apoptosis in human
osteosarcoma cells in vitro and in vivo through the upregulation of
Bax and Fas/FasL and downregulation of Bcl-2. Cancer Chemother
Pharmacol. 69:317–331. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yan LX, Wu QN, Zhang Y, Li YY, Liao DZ,
Hou JH, Fu J, Zeng MS, Yun JP, Wu QL, et al: Knockdown of miR-21 in
human breast cancer cell lines inhibits proliferation, in vitro
migration and in vivo tumor growth. Breast Cancer Res. 13:R22011.
View Article : Google Scholar : PubMed/NCBI
|
